https://www.selleckchem.com/pr....oducts/avitinib-ac00
5, all p.001). SE median duration was 24h and was extended 1.2h for each hour of treatment delay. A longer SE duration was associated with increased mortality and morbidity, both at hospital discharge and at 3-month follow-up (both p.05). After 3months, mortality was 30.1%, while recovery to baseline mRS occurred in 39.5%, with an overall median mRS of 4. There were pervasive delays in all phases of SE attention, which conditioned a longer SE duration, and this led to increased long-term morbimortality. There were pervas
Like
Comment
Share
